AGP Executive Report
Last update: 2 hours agoEbola Response in Congo: WHO-backed researchers have started a clinical trial for Bundibugyo Ebola treatments in eastern Congo, testing a monoclonal antibody (MBP134) and an antiviral (remdesivir), as cases rise to 1,406 with 438 deaths. Rapid Testing Push: A separate race for a fast antigen test has narrowed to five manufacturers, aiming for field use in mid-July to speed isolation and containment. Wildlife Monitoring in Tchimpounga: New research confirms African manatees in the Tchimpounga Nature Reserve waterways, supported by local technician training and long-term acoustic monitoring. Water Science from the Congo River: A new study maps how Congo River fresh water spreads up to 800 km offshore, using modeling and observations to track mesoscale eddies that move it far from shore. Nature-Based Climate Financing: Africa’s leaders are urged to unlock nature-based solutions with stronger, innovative financing and environmental laws—so research turns into jobs and resilience. Tech & Finance in Congo: Optasia says its microfinancing platform is gaining traction, with growth expectations that include the Republic of Congo.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
